Cardiff Oncology, Inc.

Contributing Author

Recent Articles by Cardiff Oncology, Inc.

Dec-08	Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 CRDF GlobeNewswire
Dec-08	Cardiff Oncology to Present at Sidoti's Year-End Virtual Investor Conference CRDF GlobeNewswire
Nov-24	Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare Conference CRDF GlobeNewswire
Nov-06	Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update CRDF GlobeNewswire
Nov-04	Cardiff Oncology to Participate in Two Upcoming Investor Conferences CRDF GlobeNewswire
Oct-02	Cardiff Oncology to Participate in Two Upcoming Investor Conferences CRDF GlobeNewswire
Aug-28	Cardiff Oncology to Participate in Three Upcoming Investor Conferences CRDF GlobeNewswire
Jul-29	Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004) CRDF GlobeNewswire
Jul-29	Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update CRDF GlobeNewswire
Jun-17	Cardiff Oncology Appoints Dr. Roger Sidhu as Chief Medical Officer and Announces Timing for the Next Update from the CRDF-004 Trial in First-Line RAS-mutated mCRC CRDF GlobeNewswire
Jun-02	Cardiff Oncology Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel in Metastatic Triple-Negative Breast Cancer Presented at ASCO 2025 CRDF GlobeNewswire
May-08	Cardiff Oncology Reports First Quarter 2025 Results and Provides Business Update CRDF GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.